WBAG:DBI

Stock Analysis Report

Executive Summary

Dr. Bock Industries AG produces and sells trousers for the menswear and womenswear markets in Germany.

Snowflake

Fundamentals

Imperfect balance sheet with weak fundamentals.

Risks

  • Dr. Bock Industries's last earnings update was 370 days ago.
  • Dr. Bock Industries is not covered by any analysts.

Share Price & News

How has Dr. Bock Industries's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

0%

WBAG:DBI

-0.6%

AT Luxury

-1.2%

AT Market


1 Year Return

n/a

WBAG:DBI

-31.3%

AT Luxury

-6.7%

AT Market

No trading data on DBI.

No trading data on DBI.


Share holder returns

DBIIndustryMarket
7 Day0%-0.6%-1.2%
30 Day0%-1.8%-1.2%
90 Dayn/a-9.5%-3.5%
1 Yearn/a-31.3%-31.3%-3.1%-6.7%
3 Year103.3%89.5%-22.5%-30.8%49.4%35.6%
5 Yearn/a-36.4%-47.3%50.1%28.6%

Price Volatility Vs. Market

How volatile is Dr. Bock Industries's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Dr. Bock Industries undervalued based on future cash flows and its price relative to the stock market?

866.68x

Price to Earnings (PE) ratio


Intrinsic Value Based on Future Cash Flows

Dr. Bock Industries's share price is above the future cash flow value, it's not available at a moderate discount (< 20%).

Dr. Bock Industries's share price is above the future cash flow value, it's not available at a substantial discount (< 40%).


Price Based on Earnings

Dr. Bock Industries is overvalued based on earnings compared to the Europe Luxury industry average.

Dr. Bock Industries is overvalued based on earnings compared to the Austria market.


Price Based on Expected Growth

Unable to calculate PEG ratio for Dr. Bock Industries, we can't assess if its growth is good value.


Price Based on Value of Assets

Dr. Bock Industries is overvalued based on assets compared to the Europe Luxury industry average.


Next Steps

Future Growth

How is Dr. Bock Industries expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

11.4%

Forecasted Luxury industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Dr. Bock Industries has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

Past Performance

How has Dr. Bock Industries performed over the past 5 years?

-96.2%

Last years earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Insufficient data to establish if Dr. Bock Industries's year on year earnings growth rate was positive over the past 5 years.

Dr. Bock Industries's 1-year earnings growth is negative, it can't be compared to the 5-year average.

Dr. Bock Industries's 1-year earnings growth is negative, it can't be compared to the Europe Luxury industry average.


Return on Equity

Dr. Bock Industries has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).


Return on Assets

Dr. Bock Industries used its assets less efficiently than the Europe Luxury industry average last year based on Return on Assets.


Return on Capital Employed

Dr. Bock Industries's use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).


Next Steps

Financial Health

How is Dr. Bock Industries's financial position?


Financial Position Analysis

Dr. Bock Industries's short term (1 year) commitments are greater than its holdings of cash and other short term assets.

Dr. Bock Industries's cash and other short term assets cover its long term commitments.


Debt to Equity History and Analysis

Dr. Bock Industries's level of debt (96.8%) compared to net worth is high (greater than 40%).

Unable to establish if Dr. Bock Industries's debt level has increased without past 5-year debt data.

Debt is not well covered by operating cash flow (18.3%, less than 20% of total debt).

Interest payments on debt are well covered by earnings (EBIT is 11.5x coverage).


Balance Sheet

High level of physical assets or inventory.

Debt is not covered by short term assets, assets are 0.6x debt.


Next Steps

Dividend

What is Dr. Bock Industries's current dividend yield, its reliability and sustainability?

0.83%

Current Dividend Yield


Dividend Yield and Payments Analysis

Dr. Bock Industries's pays a lower dividend yield than the bottom 25% of dividend payers in Austria (1.63%).

Dr. Bock Industries's dividend is below the markets top 25% of dividend payers in Austria (4.67%).

Dr. Bock Industries is not paying a notable dividend for Austria, therefore no need to check if the payments are stable.

Dr. Bock Industries is not paying a notable dividend for Austria, therefore no need to check if the payments are increasing.


Current Payout to Shareholders

No need to calculate the sustainability of Dr. Bock Industries's dividends as it is not paying a notable one for Austria.


Future Payout to Shareholders

Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.


Next Steps

Management

What is the CEO of Dr. Bock Industries's salary, the management and board of directors tenure and is there insider trading?

3.8yrs

Average board tenure


CEO

Tilman Erpen

Mr. Tilman Meyer Zu Erpen has been Chief Strategy Officer and Member of Management Board of Dr. Bock Industries AG since October 1, 2015 and served as its Head of the Operations Department since October 1, ...


Board Age and Tenure

3.8yrs

Average Tenure

The tenure for the Dr. Bock Industries board of directors is about average.


Insider Trading

No 3 month open market individual insider trading information.


Ownership Breakdown


Management Team

  • Tilman Erpen

    CEO, Chief Strategy Officer & Member of Management Board

  • Ulrich Glass

    CFO & Member of Management Board


Board Members

  • Abram Nette

    Member of Supervisory Board

    • Tenure: 3.8yrs
  • Thomas Gries

    Chairman of Supervisory Board

    • Tenure: 3.8yrs
  • Josef Schröder

    Member of Supervisory Board

    • Tenure: 3.8yrs

Company Information

Dr. Bock Industries AG's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Dr. Bock Industries AG
  • Ticker: DBI
  • Exchange: WBAG
  • Founded: 1984
  • Industry: apparel, accessories and luxury goods
  • Sector: consumer durables
  • Market Cap: €72.000m
  • Shares outstanding: 4.00m
  • Website: Click here

Number of Employees


Location

  • Dr. Bock Industries AG
  • Welle 23
  • Rolfshagen
  • Auetal
  • Lower Saxony
  • 31749
  • Germany

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
DBIWBAG (Wiener Boerse AG)YesShare CapitalATEURJul 2016

Biography

Dr. Bock Industries AG produces and sells trousers for the menswear and womenswear markets in Germany. The company offers various kinds of trousers, including classical trousers in wool, chinos, five pocke ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/08/14 22:23
End of Day Share Price2019/05/17 00:00
Earnings2018/06/30
Annual Earnings2017/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.